StockData
Decoy Therapeutics Inc. logo

Decoy Therapeutics Inc. (DCOY) stock

DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.95+0.05 (+5.37%)

Close on Nov 17, 2026Market cap $622.03KP/E –Yield –

Decoy Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Decoy Therapeutics's price to sales ratio was 186.5× on Jul 29, 2022, against 81.1× a year earlier. Over the last 3 years it ranged from 10.6× to 461.8×, with a median of 80.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jul 29, 2022186.5×+105.6
2021Dec 31, 202180.9×+35.8
2020Dec 31, 202045.2×−20.6
2019Dec 31, 201965.8×–

More Decoy Therapeutics figures

See a number that looks wrong?